NapaJen Pharma, Inc. — Form D
NapaJen Pharma, Inc. of BURLINGAME, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-09-17. The offering totals $2.0M, of which $500K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-09-17
- Form: D
- Accession: 0001883744-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $500K
- Remaining: $1.5M
- Investors: 1
- Date of first sale: 2021-08-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-413786
Issuer
- Name: NapaJen Pharma, Inc.
- CIK: 0001883744
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Address: 533 AIRPORT BOULEVARD, SUITE 527, BURLINGAME, CA, 94010
- Phone: 81-42-316-6773
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Taro Inaba | Director | TOKYO, M0 |
| Kazuhiko Nonomura | Director | Burlingame, CA |
| Walter Olesiak | Director | New York, NY |
| Walter Olesiak | Executive Officer | New York, NY |
More